
CHMP Recommends Jazz Pharmaceuticals Therapy for Biliary Tract Cancer
Jazz Pharmaceuticals, headquartered in Dublin, Ireland, announced on April 25, 2025 that the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion to recommend conditional marketing authorization …